Surprisingly, compared with T cell–specific deletion of PD-1, myeloid specific PD-1 deletion led to more effective inhibition of tumor growth in various tumor models, as effective as global deletion of PD-1 (4–8). The gene discussed is PDCD1; the disease is neoplasm.